{"contentid": 488085, "importid": NaN, "name": "$2 billion boost for Fujifilm's biologics business", "introduction": "Another major manufacturing investment from Japanese conglomerate Fujifilm Corp will significantly up its presence in cell culture production for biologic therapies.", "content": "<p>Another major manufacturing investment from Japanese conglomerate Fujifilm Corp (TYO: 4901) will significantly up its presence in cell culture production for biologic therapies.</p>\n<p>The Tokyo-based firm will spend $2 billion on a new large-scale facility in the USA, with the goal of expanding its contract development and manufacturing business (CDMO).</p>\n<p>The company&rsquo;s North Carolina site has been in operation since 1996. In a sign of its global ambitions, the greatly expanded facility will add to existing production centers in Texas, the UK and Denmark.</p>\n<p>The investment comes around a year after the firm spent a similar sum buying and then doubling in size Biogen's (Nasdaq: BIIB) biologics facility near Copenhagen.</p>\n<p>Fujifilm offers a comprehensive list of services from cell line development to process development, analytical development, and clinical and US FDA-approved commercial manufacturing.</p>\n<p>The firm has set a target to achieve an annual revenue of $2 billion from its biologics-focused CDMO business by the end of the Japanese fiscal year in March 2025.</p>\n<p>Shortly after this point, Fujifilm said it expects its latest investment to boost the annual growth rate of its Bio CDMO Business to 20%.</p>\n<p>President Kenji Sukeno said: &ldquo;I am pleased that through this large investment in the USA we are able to support the development and manufacturing of new drugs that can help fulfill unmet medical needs.&rdquo;</p>\n<p>&ldquo;Fujifilm will continue to promote human health and support the progress of the healthcare industry by using our cutting-edge technology and advanced facilities to provide a stable supply of high quality biopharmaceuticals,&rdquo; he added.</p>", "date": "2021-03-19 10:36:00", "meta_title": NaN, "meta_keywords": "Fujifilm, boost, manufacturing, investment, business, cell, development, billion, production, Japanese, biologics, facility, Corp, significantly, presence", "meta_description": "Another major manufacturing investment from Japanese conglomerate Fujifilm Corp will significantly boost its presence in cell culture production for biologic th", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-19 09:50:56", "updated": "2021-03-19 10:39:50", "access": NaN, "url": "https://www.thepharmaletter.com/article/2-billion-boost-for-fujifilm-s-biologics-business", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "biotech_manufacturing_big-1.jpg", "image2id": "biotech_manufacturing_small-1.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Cell and Gene Therapy", "topic_tag": "Asia Pacific, Focus On, Production", "geography_tag": "Japan, USA", "company_tag": "Fujifilm", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-19 10:36:00"}